ArticleBMJ open2026
Evaluating the efficacy of an SMS text message information and support programme for people who have experienced a motor vehicle-related injury: protocol for a double-blind randomised controlled trial.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionRoad traffic injuries can be physically and emotionally challenging, and navigating compensation processes may increase uncertainty and distress. Early high distress is linked with poorer long-term recovery, including persistent pain and delayed return to work. Digital health tools, particularly brief, scalable SMS programmes, may offer timely information and emotional support during recovery. This protocol outlines a double-blind randomised controlled trial evaluating the efficacy, feasibility and acceptability of an SMS-delivered health information and support programme for people who have lodged a compulsory third party (CTP) insurance claim after a motor-vehicle-related injury. METHODS AND ANALYSIS: This double-blind, two-arm parallel-group trial will recruit 254 adults in New South Wales, Australia, who recently sustained a motor-vehicle-related injury and lodged a CTP claim with Allianz Insurance Australia (Allianz). Participants will be randomised (1:1) to either: (1) an intervention group receiving two co-designed informational videos plus 28 days of once-daily supportive SMS messages in addition to usual care, or (2) an active control group receiving the same videos and usual care only. The primary outcome is pain self-efficacy at 30 days, assessed using the Pain Self-Efficacy Questionnaire (PSEQ-10). Secondary outcomes include claimant satisfaction, pain and pain interference, anxiety and depression, pain-related concerns, perceived social support, healthcare costs and return-to-work status. Feasibility and acceptability will be assessed using the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation and Maintenance) through engagement data, reach, satisfaction ratings and qualitative interviews. Analyses will follow intention-to-treat principles with thematic analysis for qualitative data. ETHICS AND DISSEMINATION: Ethical approval has been granted by The University of Sydney Human Research Ethics Committee (2025/HE001079). Findings will be shared through publications, conference presentations and stakeholder reports to guide future digital support initiatives in compensation settings. TRIAL REGISTRATION NUMBER: ACTRN12625001043426.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.